191 related articles for article (PubMed ID: 32150102)
1. Distinct expression and prognostic value of members of SMAD family in non-small cell lung cancer.
Zeng Z; Yang Y; Qing C; Hu Z; Huang Y; Zhou C; Li D; Jiang Y
Medicine (Baltimore); 2020 Mar; 99(10):e19451. PubMed ID: 32150102
[TBL] [Abstract][Full Text] [Related]
2. Gene expression and prognosis of insulin‑like growth factor‑binding protein family members in non‑small cell lung cancer.
Wang J; Hu ZG; Li D; Xu JX; Zeng ZG
Oncol Rep; 2019 Nov; 42(5):1981-1995. PubMed ID: 31545451
[TBL] [Abstract][Full Text] [Related]
3. Expression, Prognosis and Gene Regulation Network of NFAT Transcription Factors in Non-Small Cell Lung Cancer.
Ma J; Du R; Huang Y; Zhong W; Gui H; Mao C; Song X; Lu J
Pathol Oncol Res; 2021; 27():529240. PubMed ID: 34257525
[TBL] [Abstract][Full Text] [Related]
4. [Expression of KIF23 and Its Prognostic Role in Non-small Cell Lung Cancer:
Analysis Based on the Data-mining of Oncomine].
Ye L; Li H; Zhang F; Lv T; Liu H; Song Y
Zhongguo Fei Ai Za Zhi; 2017 Dec; 20(12):822-826. PubMed ID: 29277180
[TBL] [Abstract][Full Text] [Related]
5. Distinct prognostic values and potential drug targets of ALDH1 isoenzymes in non-small-cell lung cancer.
You Q; Guo H; Xu D
Drug Des Devel Ther; 2015; 9():5087-97. PubMed ID: 26366059
[TBL] [Abstract][Full Text] [Related]
6. Analyses of expressions and prognostic values of Polo-like kinases in non-small cell lung cancer.
Zeng Y; Li N; Liu W; Zeng M; Cheng J; Huang J
J Cancer Res Clin Oncol; 2020 Oct; 146(10):2447-2460. PubMed ID: 32627077
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Value of EZH2 in Non-Small-Cell Lung Cancers: A Meta-Analysis and Bioinformatics Analysis.
Fan K; Zhang CL; Qi YF; Dai X; Birling Y; Tan ZF; Cao F
Biomed Res Int; 2020; 2020():2380124. PubMed ID: 33299862
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the effect of NEKs on the prognosis of patients with non-small-cell lung carcinoma based on bioinformatics.
Yang M; Guo Y; Guo X; Mao Y; Zhu S; Wang N; Lu D
Sci Rep; 2022 Feb; 12(1):1705. PubMed ID: 35105934
[TBL] [Abstract][Full Text] [Related]
9. Prognostic roles of mRNA expression of notch receptors in non-small cell lung cancer.
Xiong J; Zhang X; Chen X; Wei Y; Lu DG; Han YW; Xu J; Yu D
Oncotarget; 2017 Feb; 8(8):13157-13165. PubMed ID: 28061457
[TBL] [Abstract][Full Text] [Related]
10. Identification and Integrate Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer Based on Bioinformatics Analysis.
Gong K; Zhou H; Liu H; Xie T; Luo Y; Guo H; Chen J; Tan Z; Yang Y; Xie L
Technol Cancer Res Treat; 2021; 20():15330338211060202. PubMed ID: 34825846
[No Abstract] [Full Text] [Related]
11. Mining expression and prognosis of topoisomerase isoforms in non-small-cell lung cancer by using Oncomine and Kaplan-Meier plotter.
Hou GX; Liu P; Yang J; Wen S
PLoS One; 2017; 12(3):e0174515. PubMed ID: 28355294
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of epigenetic regulatory gene expression in patients with non-small-cell lung cancer.
Tu Z; Chen X; Tian T; Chen G; Huang M
Aging (Albany NY); 2021 Feb; 13(5):7397-7415. PubMed ID: 33658396
[TBL] [Abstract][Full Text] [Related]
13. Distinct Prognostic Values of Phospholipase C Beta Family Members for Non-Small Cell Lung Carcinoma.
Zhang T; Song X; Liao X; Wang X; Zhu G; Yang C; Xie X
Biomed Res Int; 2019; 2019():4256524. PubMed ID: 31080817
[TBL] [Abstract][Full Text] [Related]
14. Identification of TIMELESS and RORA as key clock molecules of non-small cell lung cancer and the comprehensive analysis.
Xian H; Li Y; Zou B; Chen Y; Yin H; Li X; Pan Y
BMC Cancer; 2022 Jan; 22(1):107. PubMed ID: 35078435
[TBL] [Abstract][Full Text] [Related]
15. Integrated analysis of the prognostic value of TP53 dependent etoposide-induced gene 24 in non-small cell lung cancer.
Wang M; Li P; Wan R; Liu X
Biomed Pharmacother; 2019 Apr; 112():108590. PubMed ID: 30784913
[TBL] [Abstract][Full Text] [Related]
16. Role of high expression levels of STK39 in the growth, migration and invasion of non-small cell type lung cancer cells.
Li Z; Zhu W; Xiong L; Yu X; Chen X; Lin Q
Oncotarget; 2016 Sep; 7(38):61366-61377. PubMed ID: 27542260
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive analysis of non-small-cell lung cancer microarray datasets identifies several prognostic biomarkers.
Qin X; Chen R; Xiong R; Tan Z; Gao S; Lin C; Huo T
Future Oncol; 2019 Sep; 15(27):3135-3148. PubMed ID: 31426680
[No Abstract] [Full Text] [Related]
18. Elevated integrin α6β4 expression is associated with venous invasion and decreased overall survival in non-small cell lung cancer.
Stewart RL; West D; Wang C; Weiss HL; Gal T; Durbin EB; O'Connor W; Chen M; O'Connor KL
Hum Pathol; 2016 Aug; 54():174-83. PubMed ID: 27107458
[TBL] [Abstract][Full Text] [Related]
19. The Regulatory Network and Potential Role of LINC00973-miRNA-mRNA ceRNA in the Progression of Non-Small-Cell Lung Cancer.
Guo Q; Li D; Luo X; Yuan Y; Li T; Liu H; Wang X
Front Immunol; 2021; 12():684807. PubMed ID: 34394080
[TBL] [Abstract][Full Text] [Related]
20. Serum microRNA-365 in combination with its target gene TTF-1 as a non-invasive prognostic marker for non-small cell lung cancer.
Liu Y; Zhang G; Li H; Han L; Fu A; Zhang N; Zheng Y
Biomed Pharmacother; 2015 Oct; 75():185-90. PubMed ID: 26337230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
